The US Food and Drug Administration approved fenfluramine for Lennox-Gastaut syndrome based on data that found that the frequency of certain seizure subtypes, notably generalized tonic-clonic seizures, dropped in a dose-dependent way compared with a group taking placebo.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045